Effectiveness of Weight Loss Methods on Lifespan for Metabolic Syndrome

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 220 participants.

Also called NCT06410352

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 220 participants (planned count) (from the registry)
Sponsor
University Medical Center, Kazakhstan (from the registry)
Registry
  • NCT NCT06410352
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Kazakhstan (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06410352. Non-randomized; no masking; primary purpose treatment. Start 2024-03-01 (actual); primary completion 2025-09-30 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Effectiveness of Weight Loss Methods on Lifespan for Metabolic Syndrome
Intervention (Drug)
Semaglutide, Empagliflozin
Intervention (Procedure)
Minigastric bypass
Intervention (Dietary supplement)
Analimentary detoxication
Intervention (Behavioral)
Ramadan fast's weight loss
Lead sponsor
University Medical Center, Kazakhstan (class: other)
Collaborator
Nazarbayev University School of Medicine (class: not stated)
Collaborator
Nazarbayev University (class: other)
Collaborator
Astana Medical University (class: other)
Collaborator
Public Association "Eurasian Society of Personalized Medicine" (class: not stated)
Collaborator
Ministry of Science and Higher Education of the Republic of Kazakhstan (class: other government)

Record details

Record id
cardio:ct-nct06410352
Content hash
63ce2f658eeb8b7f819030cea4416d73523b85a064c9643df60246c6db45aab5